Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 223

1.

Perioperative Statin Use and Acute Kidney Injury in Patients Undergoing Partial Nephrectomy.

Joshi SS, Ruth K, Smaldone MC, Chen DYT, Greenberg RE, Viterbo R, Kutikov A, Uzzo RG.

Kidney Cancer. 2018 Mar 30;2(1):47-55. doi: 10.3233/KCA-180031.

2.

Robotic versus laparoscopic radical nephrectomy: a large multi-institutional analysis (ROSULA Collaborative Group).

Anele UA, Marchioni M, Yang B, Simone G, Uzzo RG, Lau C, Mir MC, Capitanio U, Porter J, Jacobsohn K, de Luyk N, Mari A, Chang K, Fiori C, Sulek J, Mottrie A, White W, Perdona S, Quarto G, Bindayi A, Ashrafi A, Schips L, Berardinelli F, Zhang C, Gallucci M, Ramirez-Backhaus M, Larcher A, Kilday P, Liao M, Langenstroer P, Dasgupta P, Challacombe B, Kutikov A, Minervini A, Rha KH, Sundaram CP, Hampton LJ, Porpiglia F, Aron M, Derweesh I, Autorino R.

World J Urol. 2019 Feb 7. doi: 10.1007/s00345-019-02657-2. [Epub ahead of print]

PMID:
30734072
3.

Spontaneous resolution of a 10 cm heterogenous renal lesion upon expectant management.

Lee M, Lee Z, Kutikov A.

Urol Case Rep. 2019 Jan 14;23:85-86. doi: 10.1016/j.eucr.2019.01.008. eCollection 2019 Mar.

4.

A national survey of radiation oncologists and urologists on prediction tools and nomograms for localized prostate cancer.

Gershman B, Maroni P, Tilburt JC, Volk RJ, Konety B, Bennett CL, Kutikov A, Smaldone MC, Chen V, Kim SP.

World J Urol. 2019 Jan 22. doi: 10.1007/s00345-019-02637-6. [Epub ahead of print]

PMID:
30671637
5.

Needle Tract Seeding Following Renal Tumor Biopsy: Scarcely a Concern or a Concern to Scare?

Ahmad AE, Kutikov A, Finelli A.

Eur Urol. 2019 Jan 11. pii: S0302-2838(19)30007-7. doi: 10.1016/j.eururo.2019.01.006. [Epub ahead of print] No abstract available.

PMID:
30642611
6.

Incisional hernia after cystectomy: incidence, risk factors and anthropometric predisposition.

Edwards DC, Cahn DB, Reddy M, Kivlin D, Malhotra A, Li T, Chen DYT, Viterbo R, Uzzo RG, Greenberg RE, Smaldone MC, Curcillo P, Kutikov A.

Can J Urol. 2018 Dec;25(6):9573-9578.

PMID:
30553281
7.

Neoadjuvant chemotherapy for penile cancer enabling organ preservation: A case of individualized management for bilateral lymph node metastasis and a bulky primary tumor.

Asghar AM, McIntosh AG, Kutikov A, Chen DY, Geynisman DM.

Urol Case Rep. 2018 Nov 9;23:3-5. doi: 10.1016/j.eucr.2018.11.002. eCollection 2019 Mar. No abstract available.

8.

Assessment of volume preservation performed before or after partial nephrectomy accurately predicts postoperative renal function: Results from a prospective multicenter study.

Klingler MJ, Babitz SK, Kutikov A, Campi R, Hatzichristodoulou G, Sanguedolce F, Brookman-May S, Akdogan B, Capitanio U, Roscigno M, Volpe A, Marszalek M, Uzzo RG, Antonelli A, Langenhuijsen J, Carini M, Minervini A, Lane BR.

Urol Oncol. 2019 Jan;37(1):33-39. doi: 10.1016/j.urolonc.2018.11.007. Epub 2018 Nov 23.

PMID:
30473205
9.

Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 Trial.

Anari F, O'Neill J, Choi W, Chen DYT, Haseebuddin M, Kutikov A, Dulaimi E, Alpaugh RK, Devarajan K, Greenberg RE, Bilusic M, Wong YN, Viterbo R, Hoffman-Censits JH, Lallas CD, Trabulsi EJ, Smaldone M, Geynisman DM, Zibelman M, Lin J, Kelly WK, Uzzo R, McConkey D, Plimack ER.

Eur Urol Oncol. 2018 May;1(1):54-60. doi: 10.1016/j.euo.2018.02.007. Epub 2018 Jun 6.

PMID:
30420974
10.

Robotic Inferior Vena Cava Thrombectomy: Are We Entering the House Through an Attic Window?

Masic S, Kutikov A.

Eur Urol Focus. 2018 Sep;4(5):641-642. doi: 10.1016/j.euf.2018.10.012. Epub 2018 Nov 8.

PMID:
30415922
11.

The Association of Robot-assisted Versus Pure Laparoscopic Radical Nephrectomy with Perioperative Outcomes and Hospital Costs.

Gershman B, Bukavina L, Chen Z, Konety B, Schumache F, Li L, Kutikov A, Smaldone M, Abouassaly R, Kim SP.

Eur Urol Focus. 2018 Oct 22. pii: S2405-4569(18)30297-9. doi: 10.1016/j.euf.2018.10.004. [Epub ahead of print]

PMID:
30361146
12.

Ischemia Techniques in Nephron-sparing Surgery: A Systematic Review and Meta-Analysis of Surgical, Oncological, and Functional Outcomes.

Greco F, Autorino R, Altieri V, Campbell S, Ficarra V, Gill I, Kutikov A, Mottrie A, Mirone V, van Poppel H.

Eur Urol. 2019 Mar;75(3):477-491. doi: 10.1016/j.eururo.2018.10.005. Epub 2018 Oct 13. Review.

PMID:
30327272
13.

Renal Hilar Lesions: Biological Implications for Complex Partial Nephrectomy.

Correa AF, Yankey H, Li T, Joshi SS, Kutikov A, Chen DY, Viterbo R, Greenberg RE, Smaldone MC, Uzzo RG.

Urology. 2019 Jan;123:174-180. doi: 10.1016/j.urology.2018.08.044. Epub 2018 Oct 6.

PMID:
30296503
14.

Perceptions of Prostate MRI and Fusion Biopsy of Radiation Oncologists and Urologists for Patients Diagnosed with Prostate Cancer: Results from a National Survey.

Bukavina L, Tilburt JC, Konety B, Shah ND, Gross CP, Yu JB, Schumacher F, Kutikov A, Smaldone MC, Kim SP.

Eur Urol Focus. 2018 Sep 12. pii: S2405-4569(18)30256-6. doi: 10.1016/j.euf.2018.09.002. [Epub ahead of print]

PMID:
30219709
15.

Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.

Ristau BT, Handorf EA, Cahn DB, Kutikov A, Uzzo RG, Smaldone MC.

Cancer. 2018 Oct 1;124(19):3839-3848. doi: 10.1002/cncr.31582. Epub 2018 Sep 12.

PMID:
30207380
16.

Online Professionalism-2018 Update of European Association of Urology (@Uroweb) Recommendations on the Appropriate Use of Social Media.

Borgmann H, Cooperberg M, Murphy D, Loeb S, N'Dow J, Ribal MJ, Woo H, RouprĂȘt M, Winterbottom A, Wijburg C, Wirth M, Catto J, Kutikov A.

Eur Urol. 2018 Nov;74(5):644-650. doi: 10.1016/j.eururo.2018.08.022. Epub 2018 Sep 1. Review.

PMID:
30177286
17.

Functional Parenchymal Volume-based Spectrum Score Is Able to Quantify Ischemic Injury After Partial Nephrectomy.

Lee Z, Uzzo R, Asghar A, Parkansky P, Botejue M, Li T, Viterbo R, Chen DYT, Smaldone M, Kutikov A.

Urology. 2018 Oct;120:150-155. doi: 10.1016/j.urology.2018.07.027. Epub 2018 Jul 29.

PMID:
30063909
18.

Comparative Effectiveness of Local and Systemic Therapy for T4 Prostate Cancer.

Kim AH, Konety B, Chen Z, Schumacher F, Kutikov A, Smaldone M, Abouassaly R, Khanna A, Kim SP.

Urology. 2018 Oct;120:173-179. doi: 10.1016/j.urology.2018.06.038. Epub 2018 Jul 7.

PMID:
29990574
19.

Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies.

Makhov P, Joshi S, Ghatalia P, Kutikov A, Uzzo RG, Kolenko VM.

Mol Cancer Ther. 2018 Jul;17(7):1355-1364. doi: 10.1158/1535-7163.MCT-17-1299. Review.

PMID:
29967214
20.

Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-based Analysis.

Joshi SS, Handorf EA, Zibelman M, Plimack ER, Uzzo RG, Kutikov A, Smaldone MC, Geynisman DM.

Eur Urol. 2018 Sep;74(3):387-393. doi: 10.1016/j.eururo.2018.05.025. Epub 2018 Jun 5.

PMID:
29880274

Supplemental Content

Loading ...
Support Center